HYDROANTHRACENE BASED COMPOUNDS AS ANTICANCER AGENTS
Details for Australian Patent Application No. 2003249588 (hide)
International Classifications
Event Publications
16 October 2003 Complete Application Filed
Priority application(s): 10/426,026 29.04.03 US
23 December 2004 Application Open to Public Inspection
Published as AU-A-2003249588
17 September 2009 Assignment before Grant
Dabur Research Foundation The application has been assigned to Dabur Pharma Limited
12 August 2010 Application Accepted
Published as AU-A-2003249588
9 December 2010 Standard Patent Sealed
23 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser